Streetwise Reports' Article Archives — January 2022 back to current month (102)
New Silver Producer Won't Forget Exploration Roots (01/31/2022)
With its new processing plant at the Juanicipio project in Mexico, MAG Silver is moving toward being a producer. But its president and CEO says it won't forget its explorer DNA.
Explorer to Update Resource Report in 2022 (01/31/2022)
Couloir Capital Ltd. commented in a research note that the vast resources outlined by Group Ten Metals at its Stillwater West Property offer strong potential for near-term upgrades and future resource expansion.
Co. Focused on Pipeline of Drug Candidates (01/31/2022)
In the clinic, Algernon Pharmaceuticals is advancing Ifenprodil in three indications and DMT in stroke, noted a Research Capital Corp. report.
Gold Explorer Has Projects in Nevada, Oregon (01/31/2022)
Provenance Gold has two potential multimillion ounce bulk tonnage gold projects in Nevada and Oregon.
Shares of Provention Bio Inc. traded 29% higher after the company reported that following its Type B meeting and conversations with the U.S. FDA, it is now planning to resubmit a Biologics License Application for delay of clinical type 1 diabetes in at-risk individuals.
Scottie Resources Delivers Excellent Drill Results (01/30/2022)
Bob Moriarty of 321 Gold explains why he is a believer in Scottie Resources, which owns 52,000 ha of prime ground in British Columbia's Golden Triangle.
ProMIS Neurosciences appointed to its science advisory board Canada-based Dr. Cheryl Wellington, professor, neuroscientist and head of a globally recognized neuro research program.
During Streetwise Live! on Jan. 27, 2022, representatives of Algernon Pharmaceuticals discussed the use of the psychedelic DMT in stroke sufferers. On the broadcast were Algernon CEO Christopher Moreau and consultants to the firm, Dr. David Nutt and Dr. Rick Strassman.
Analyst coverage was initiated on UGE International, the share price of which has significant upside potential, noted an iA Capital Markets report.
Troilus Gold Corp. released drill results from eight new holes at its Troilus property. A mining analyst at Laurentian Bank Securities Equity Research commented in a research note that the results appear to confirm that the Southwest Zone is the project's "Center of Gravity".
Co. Meets Goals in COVID Drug Trial (01/28/2022)
Todos Medical has closed a Phase 2 trial of its antiviral 3CL protease inhibitor Tollovir after getting positive interim data.
FDA Approves First Tubeless Insulin Delivery Device (01/28/2022)
Shares of Insulet Corp. traded 15% higher after the company reported its Omnipod® 5 automated insulin delivery system has received clearance from the U.S. FDA. The Omnipod® 5 is the first tubeless system to be monitored and controlled remotely using a smartphone.
This agreement, which could lead to Crown Electrokinetics providing its Smart Window inserts to Hudson Pacific Properties, could represent about a $100 million opportunity for the tech firm, noted a Dawson James Securities Inc. report.
This Junior Miner Is Looking for Big Gold (01/27/2022)
The Critical Investor is looking into Aztec Minerals, which is aiming to delineate two oxide deposits in Mexico and Arizona, both with large scale porphyry/CRD potential at depth.
Hard Drive Maker Posts 18% YoY Growth in Q2 Revenue (01/27/2022)
Shares of hard drive storage maker Seagate Technology Holdings Plc. traded 8% higher after the company reported Q2/22 financial results that featured 39% YoY increase in free cash flow.
Forward Water Technologies Corp. is exploring applications for its forward osmosis water technology in the lithium extraction industry.
The master supply agreement between Crown Electrokinetics and Hudson Pacific Properties is likely a precursor to purchase orders being placed in 2022, noted a ROTH Capital Partners report.
Corning Inc. shares traded 11% higher after the company reported Q4/21 and FY/21 financial results highlighting a 23% YoY increase in core sales.
Lion One Metals' infill drilling at its Tuvatu gold project in Fiji, in an area earmarked for early production, has defined "exceptionally high-grade mineralization."
Vancouver-based junior Barsele Minerals Corp. is taking the rare step of trying to buy out its major partner, Agnico Eagle Mines Ltd.
Possible Treatment for CRC Shows Promise (01/25/2022)
New trial results of Exelixis' cabozantinib in colorectal cancer are encouraging for further development of the biopharma's XL902 in the indication, noted an H.C. Wainwright & Co. report.
Technical Analyst Clive Maund dissects Lion One's stock chart and explains why he sees this to be a "great buy spot" for the company's stock.
Copper Mining Co. Trading at a Discount (01/25/2022)
Coverage was initiated on World Copper, which has Q1/22 catalysts and 2022 exploration plans for all three of its properties, noted a Fundamental Research Corp. report.
Algernon Pharmaceuticals Inc. has included novel salt forms of a psychedelic drug being investigated to combat strokes in its intellectual property applications.
Michael Ballanger discusses whether gold and silver (and their equities) will decouple from correlation with the broad stock market.
Copper, Gold Mining Explorer to Go Public (01/25/2022)
Zacapa Resources will complete its initial public offering and be listed on the TSX Venture Exchange on Jan. 26.
Explorer of Metals to Start Drilling Soon (01/25/2022)
With this impending program, Newrange Gold will drill test priority targets at its North Birch and Argosy projects northeast of Ontario's Red Lake.
Bone Cancer Drug Meets Goals, Stocks Rise (01/25/2022)
Shares of Sierra Oncology Inc. traded 48% higher after the company reported that topline data obtained during its Pivotal Phase 3 MOMENTUM Myelofibrosis Study showed that its momelotinib produced statistically significant improvements in anemia and splenic size.
Bob Moriarty of 321 Gold explains why he is an investor in Reyna Gold, an explorer with projects in northern Mexico that began publicly trading earlier this month.
OOOOO Entertainment Commerce and QVC Italia debut likeQ, their new interactive livestream shopping app in Italy.
Red Metal Resources plans a 2,000 meter diamond drill plan, testing two sets of targets shown, via previous exploration efforts, to be prospective.
Now with fast track status and positive Phase 1 study results, Antares Pharma plans to advance its ATRS-1902 product candidate into a second trial in Q2/22, noted a Ladenburg Thalmann report.
Fourth COVID-19 Vaccine Shot Shown Less Effective (01/24/2022)
BioNTech aims to develop a COVID-19 vaccine targeting the Omicron variant, noted an H.C. Wainwright & Co. report.
‘Strong Data’ Expected From Todos Medical Data Lock (01/24/2022)
Todos Medical is set to take on the dominant players in oral antivirals for mild to moderate COVID-19, Pfizer Inc. and Merck & Co. Inc., with "strong data" expected to be released soon for its drug Tollovir.
Natural Gas Supplier Buys Energy Infrastructure Firm (01/24/2022)
Shares of full-service oil & gas solutions provider Exterran Corp. traded 60% higher after the company reported it agreed to be acquired by Enerflex Ltd. of Canada in an all-stock transaction for US$735 million.
Should You Add to Resource Stock Positions Now? (01/24/2022)
Adrian Day reviews updates from several resource companies and discusses whether this is the time to load up.
Shares of Limelight Networks Inc. traded nearly 14% higher last Friday after the digital media content platform operator reported record Q4/21 financial results and advised that it expects the strong upward momentum to continue in FY/22.
GNC to Distribute Products for CBD Co. (01/22/2022)
The agreement with GNC is a step toward Charlotte's Web Holdings' goals of expanding consumer access to its products and becoming cash flow positive this year, noted a ROTH Capital Partners report.
First NSCLC Patient Dosed With Trial Therapeutic (01/22/2022)
Two recent Vaccitech events, the MAGE trial initial dosing and the acquisition of Avidea's SNAPvax technology, bode well for its ChAdOx1-MVA platform, noted an H.C. Wainwright & Co. report.
Solar is back. A 10-year chart of the Invesco Solar ETF (TAN) of solar-based stocks shows the surge in price and volume. This pull-back in the sector provides a buying opportunity.
Fund Triples Holding of Drug Repurposing Firm (01/20/2022)
Several events slated to happen this year could boost Algernon Pharmaceuticals' share price, noted an AlphaNorth Partners Fund performance report.
After acquiring the W2 Copper-Nickel-PGE project in Ontario, Platinex adopted a new dual strategy by going back to its roots, which involved platinum group elements (PGE), but is also in the process of revitalizing its large and prospective Shining Tree gold exploration project in the Abitibi Greenstone Belt, also in Ontario, writes The Critical Investor.
Eskay Mining Announces 239 Meters of US$143 Rock (01/20/2022)
Bob Moriarty of 321gold discusses the high-grade drill results Eskay Mining just released from its summer exploration program at its project in British Columbia's Golden Triangle.
Luxury Car Maker Seeks Self-Driving Tech (01/20/2022)
Shares of Luminar Technologies Inc. traded 11.5% higher after the company reported it formed a collaborative partnership to integrate its enhanced safety and autonomy technology in the production of Mercedes-Benz passenger vehicles.
Mining Co. Kicks Off 2022 Strongly (01/19/2022)
Aurania Resources restarted exploring the Awacha target at its Lost Cities–Cutucu project in Ecuador, noted a Noble Capital Markets report.
Inflation in the Crosshairs (01/19/2022)
Michael Ballanger delves into inflation, the Fed's actions, and how they affect precious metals investing.
US Cannabis Firm in 'State of Flux' (01/19/2022)
With several market factors working against Stem Holdings, its future is uncertain, noted a Noble Capital Markets report.
Investor Says Clean Energy Stock Set to Move (01/19/2022)
PennyQueen explains why you should care about Jericho Energy Ventures Inc.'s announcement that it has led the investment into a company developing a new class of hydrogen electrolyzer.
Adrian Day of Global Analyst takes a look at the macro picture in light of Fed Chairman Jerome Powell's more hawkish comments last week and also reviews recent developments at some companies on his list.
Jericho Energy Ventures' latest foray into the burgeoning hydrogen energy market is as the lead seed capital investor in a company with disruptive electrolyzer technology.
Shares of Zogenix Inc. rose by 66% after the company reported it entered into an agreement to be acquired by UCB. S.A. of Belgium for $26.00 per share in cash. The offer includes the potential for an additional $2.00 per share if a specific drug approval milestone is met.
The start of the C-Scan study would be a major milestone for Check-Cap, noted an H.C. Wainwright & Co. report.
Derm Biopharma Named Top Growth Pick For 2022 (01/18/2022)
Journey Medical should increase 2022 and 2023 revenue by at least 30% such that it could turn a profit in 2024, noted a ROTH Capital Partners report.
Why PennyQueen Likes This Energy Stock (01/18/2022)
PennyQueen explains why she thinks this uranium explorer is a great pick and why the metal should have an especially auspicious season.
Microsoft's Call of Duty to Buy Candy Crush for $69B (01/18/2022)
Shares of Activision Blizzard Inc. traded 26% higher after the developer and publisher of World of Warcraft® and Call of Duty® reported it agreed to be acquired by Microsoft Inc. for $95 per share in cash.
Uranium Price Forecast 2022, Growth Expected (01/17/2022)
Political unrest in Kazakhstan and a buildup of stockpiles is leading to tightened demand and opportunities for growth in uranium, according to an industry report.
Shades of Great Bear in Metals Creek (01/17/2022)
With two strong projects in a Tier One jurisdiction and experienced management and geological teams, Metals Creek Resources Ltd. could be ready for a breakout.
This Pharmaceutical Company Has a Brilliant Concept (01/17/2022)
Algernon Pharmaceuticals is a clinical-stage, small biotech that boasts a massive pipeline of lower risk and efficient drugs. Catalysts abound with this genius repurposing company.
Hydrogen Stock at Great Entry Point (01/17/2022)
Following a severe downtrend, charts show Jericho Energy Ventures Inc. could be about to take off, analyst Clive Maund says.
Uranium Explorer Expecting Drill Results Soon (01/16/2022)
The Critical Investor discusses the latest developments for Blue Sky Uranium with CEO Niko Cacos, as a new drill program at Ivana has commenced, and the company has won a lawsuit.
BC Junior Looks to Boost Status in Golden Triangle (01/15/2022)
If your neighbors sell their house, the sale price will tell you a lot about the value of your home. In British Columbia’s Golden Triangle, companies with mines and well-defined resource development plans are getting taken out and the remaining players — and their investors — can see the favorable writing on the wall.
After semiconductor sales shattered records in 2021 amid an ongoing supply shortage, chip manufacturers are forecasting another year of growth in 2022. An overwhelming digital transformation is expected to ramp up this year across multiple industries, which could subsequently bring over half a trillion dollars to the semiconductor industry, writes McAlinden Research Partners.
The Critical Investor provides a quick update about Argentina Lithium, after they announced the acquisition of more lithium projects, on the back of a C$6M raise. All this when lithium product prices are breaking record after record.
Sell-Side Research Started On Copper Mining Co. (01/13/2022)
World Copper continues to execute its strategy of acquiring and advancing copper projects, with lots of work planned for 2022, noted a Zacks Small-Cap Research report.
After Kenorland Minerals announced its latest batch of drill results, the Critical Investor took the opportunity to do an extensive interview with CEO Zach Flood to discuss results, programs, strategy, and projects for 2022.
Shares of leading homebuilder KB Home rose 16% after the company reported Q4/21 and FY/21 financial results that included substantial increases in revenues and margins fueled by rising sales prices and demand for new homes nationwide.
Successful Junior Miner Sees Cash Flow (01/13/2022)
Michael Sheikh explains what makes Guanajuato Silver Co. a unique opportunity and takes a look at five other companies that caught his eye.
Get Ballanger's Top Picks for 2022 (01/12/2022)
Sector expert Michael Ballanger finds himself at an investing crossroads. Find out what his top picks are for 2022.
Bob Moriarty of 321Gold shares his thoughts on Goliath Resources' outstanding drill results, which they just announced on Tuesday.
Progress at Several Top Resource Companies (01/12/2022)
In this update, Adrian Day discusses some recent developments that occurred over the holidays, or otherwise got lost in the shuffle.
Ph1 Trial Results of Dementia Drug Positive (01/12/2022)
Anavex Life Sciences' study of Anavex 3-71 in frontotemporal dementia met primary and secondary safety endpoints, noted a Dawson James Securities report.
Pluristem Therapeutics and Tnuva will incorporate a new company that will use its own funding and resources to develop cell-based synthetic meat products, noted a Dawson James Securities report.
Shares of new class synthetic vaccine developer Vaxxinity Inc. traded 23% higher after the company reported it has dosed the first patient in its Phase 1b UB-312 Parkinson's disease study.
Newrange Expands Gold Search in 2022 (01/11/2022)
Newrange Gold Corp. is expanding its search for precious minerals from one project to three in 2022 and looking at the big picture at its flagship operation in Nevada.
Media Co. Gets New Listing on CSE (01/11/2022)
Mijem Newcomm Tech is going public to capitalize on the cryptocurrencies trend, given it now rewards users of its marketplace app with Bitcoin SV.
Financial Firm Recommends Royalty and Streaming Cos. (01/11/2022)
These companies are attractive now because, unlike mining operators, they are insulated from inflationary costs, noted a BMO Capital Markets report.
COVID and supply chain constraints hampered its Q4/21 production, but Riot Blockchain is bullish on its 2022 performance, noted a ROTH Capital Partners report.
Biotech Co. Partners With Life Sciences Firms (01/11/2022)
2seventy entered agreements with Novo Nordisk and Genevant to get an in vivo gene editing treatment for hemophilia A developed, noted a Wedbush report.
Analyst Stands at Crossroads in 2022 (01/11/2022)
With the accelerating involvement of government in the day-to-day behavior of all markets, it's a near-impossibility to forecast what will happen in 2022, Michael Ballanger says.
Reyna Gold, approved for listing on Toronto's Venture Exchange, finds high-grade gold in samples from La Gloria that highlight the project's potential.
Accolade Inc. shares rose 27% after the company reported Q3/22 financial results that included a 117% increase in YoY revenue. The firm highlighted that in calendar year 2021, its membership increased four-fold from 2 million to 10 million.
2022 to Be Catalyst Rich for Biopharma (01/10/2022)
The potential stock-moving events for Infinity Pharmaceuticals this year include the launch of two clinical trials and readouts from four studies, noted an H.C. Wainwright & Co. report.
Enrollment Done for COVID-19 Drug Trial (01/10/2022)
Part 2 of First Wave BioPharma's RESERVOIR trial of niclosamide to remove the SARS-CoV-2 virus from the GI tract is underway, noted a ROTH Capital Partners report.
Social gamer Zynga traded 40% higher after the company agreed to be acquired by Take-Two Interactive Inc. in a combination stock and cash transaction for $9.861 per share.
The Critical Investor was asked again by Streetwise Reports to provide his top 7 picks for the new year — at a point where the COVID-19 pandemic is playing out the Omicron variant, inflation is reaching levels not seen in decades, the Fed surprising the markets with a more hawkish stance than anticipated, with metal prices at very high levels although gold and silver seem to be consolidating and setting up for a breakout.
Gritstone bio Inc.'s lower-dose samRNA vaccines include a broader immune response to SARS-CoV-2 and may provide better protection against emerging variants. BTIG research has issued a "Buy" rating for Gritstone bio.
AI Driven Drug Firm Partners With Merck (01/07/2022)
Shares of Absci Corp. rose 18% after the company reported it is collaborating with Merck & Co. to create enzymes using its deep-learning Integrated Drug Creation™ platform and Bionic Protein™ technologies.
Logiq Board OKs Splitting Into 2 Companies (01/06/2022)
E-commerce customer acquisition solutions company Logiq Inc. plans to separate into two publicly traded companies this month, President and Executive Chairman Brent Suen says.
2022 Could See Shipping Co. Dividends, Buybacks (01/06/2022)
Noble Capital Markets has an Outperform rating and a $45 per share price target on Euroseas Ltd. given the company's favorable outlook for 2022.
Mining companies finished 2021 strongly with a 7.3% gain in Q4/21, reported Noble Capital Markets in a research note.
Co. Partners to Test New Cancer Vaccines (01/06/2022)
Genocea Biosciences Inc. is teaming up with Janssen Biotech to explore the immunogenicity of neoantigens and the role and impact of Inhibigens™ in potential vaccine therapies for cancer. H.C. Wainwright & Co. advised that it currently has a "Buy" rating on Genocea.
Shares of Vocera Communications Inc. traded nearly 27% higher after the company reported it entered into a definitive agreement to be acquired by Stryker Corp. for $79.25 per share in cash.
Analyst Says Co.'s Stock Could Skyrocket (01/06/2022)
Analyst Clive Maund says Kainantu Resources Ltd.'s stock could take off if it makes a discovery at its properties in Papua New Guinea.
Chen Lin's Top 6 Investment Ideas (01/05/2022)
In a recent interview with Streetwise Reports, family assets manager and contributing writer, Chen Lin, shared the six (mostly mid-cap) companies that are his top investment picks for 2022.
New Muscular Dystrophy Drug Shows Promise (01/05/2022)
Edgewise Therapeutics shares traded 24% higher after the company reported its EDG-5506 significantly lowered muscle damage biomarkers in adults after just two weeks of dosing in its Becker muscular dystrophy trial.
Firm to Start Exploration After Survey Results (01/05/2022)
Results of a three-dimensional interpretation of a survey at its Eskay claims could be a major catalyst for Garibaldi Resources, Noble Capital Markets said in a research note.
Co. Plans to Make 100M Rapid COVID Tests Monthly (01/05/2022)
Biopharmaceutical firm Sorrento Therapeutics Inc. plans to mobilize a fully automated assembly line in San Diego, Calif., capable of producing 6 million rapid antigen detection COVISTIX testing units per month starting in Q1/22.
Tech Growth Pushes Co.'s Rating Higher (01/04/2022)
"We expect strong datacom sales will enable II-VI to exceed Street expectations [in 2022]," noted a Raymond James report.
Shares of land-focused oil services firm NexTier Oilfield Solutions Inc. traded 27% higher after the company reported it expects Q4/21 revenues will be in the range of $500-510 million and advised that its 32-unit fracking rig fleet will be fully deployed in Q1/22.
Skyharbour Looks to New Uranium Claims (01/03/2022)
Skyharbour Resources Ltd. has staked six new prospective uranium exploration properties within and near the Athabasca Basin of northern Saskatchewan, which contains the world’s highest-grade uranium deposits.
Imperial Helium Expects Its First Sales in 2022 (01/03/2022)
Imperial Helium’s second, future-producing helium well was spud on Dec. 6, 2021, amidst constrained global helium supply. The outlook is good for 2022.
Lead Cancer Drug Gets Fast Tracked (01/03/2022)
Shares of Genprex Inc. traded 165% higher after the company reported the U.S. FDA has awarded Fast Track Designation for its REQORSA™ Immunogene Therapy for use in combination with Merck & Co.'s Keytruda® for non-small cell lung cancer treatment.
|"Zone 5 at LIO's Tuvatu recently returned 2.4m of 90.76 g/t Au."|
|"It's hard to believe DV is still at such a relatively low price."|
|"We are impressed with strong operating results from MAG's Juanicipio."|
|"MMG looks like a Strong Buy here."|
|"Tudor's request to cancel SEA's license for KSM was not successful."|